Cargando…

DOT1L: a new therapeutic target for aggressive breast cancer

Detalles Bibliográficos
Autores principales: Lee, Jeong-Yeon, Kong, Gu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741543/
https://www.ncbi.nlm.nih.gov/pubmed/26427043
_version_ 1782414014732566528
author Lee, Jeong-Yeon
Kong, Gu
author_facet Lee, Jeong-Yeon
Kong, Gu
author_sort Lee, Jeong-Yeon
collection PubMed
description
format Online
Article
Text
id pubmed-4741543
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-47415432016-03-03 DOT1L: a new therapeutic target for aggressive breast cancer Lee, Jeong-Yeon Kong, Gu Oncotarget Editorial: Chromosome Impact Journals LLC 2015-09-28 /pmc/articles/PMC4741543/ /pubmed/26427043 Text en Copyright: © 2015 Lee and Kong http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Editorial: Chromosome
Lee, Jeong-Yeon
Kong, Gu
DOT1L: a new therapeutic target for aggressive breast cancer
title DOT1L: a new therapeutic target for aggressive breast cancer
title_full DOT1L: a new therapeutic target for aggressive breast cancer
title_fullStr DOT1L: a new therapeutic target for aggressive breast cancer
title_full_unstemmed DOT1L: a new therapeutic target for aggressive breast cancer
title_short DOT1L: a new therapeutic target for aggressive breast cancer
title_sort dot1l: a new therapeutic target for aggressive breast cancer
topic Editorial: Chromosome
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741543/
https://www.ncbi.nlm.nih.gov/pubmed/26427043
work_keys_str_mv AT leejeongyeon dot1lanewtherapeutictargetforaggressivebreastcancer
AT konggu dot1lanewtherapeutictargetforaggressivebreastcancer